EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Cerebral microbleeds: A new dilemma in stroke medicine

Puneet Kakar, Andreas Charidimou, David J Werring

JRSM Cardiovascular Disease · 2012

DOI: 10.1177/2048004012474754 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift JRSM Cardiovascular Disease, 2012. Verfasst von Puneet Kakar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Stroke Medicine, Imperial College Healthcare NHS Trust , London W6 8RF , UK. Die Arbeit wurde bisher 12-mal zitiert (Crossref) und nennt 80 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cerebral microbleeds (CMBs) are an increasingly common neuroimaging finding in the context of ageing, cerebrovascular disease and dementia, with potentially important clinical relevance. Perhaps the most pressing clinical question is whether CMBs are associated with a clinically important increase in the risk of intracerebral haemorrhage (ICH), the most feared complication in patients treated with thrombolytic or antithrombotic (antiplatelet and anticoagulant) drugs. This review will summarize the evidence available regarding CMBs as an indicator of future ICH risk in stroke medicine clinical practice.

Autor:innen und Institutionen

  • Department of Stroke Medicine, Imperial College Healthcare NHS Trust , London W6 8RF , UK.

Zitieren

APA

Kakar, P., Charidimou, A., & Werring, D. J. (2012). Cerebral microbleeds: A new dilemma in stroke medicine. JRSM Cardiovascular Disease. https://doi.org/10.1177/2048004012474754

Vancouver

Kakar P, Charidimou A, Werring DJ. Cerebral microbleeds: A new dilemma in stroke medicine. JRSM Cardiovascular Disease. 2012. doi:10.1177/2048004012474754

BibTeX
@article{Kakar2012,
  author = {Kakar, Puneet and Charidimou, Andreas and Werring, David J},
  title = {Cerebral microbleeds: A new dilemma in stroke medicine},
  journal = {JRSM Cardiovascular Disease},
  year = {2012},
  doi = {10.1177/2048004012474754}
}
Kostenlos starten →